Immunohistochemical expression of Annexin A5 in preeclamptic placentas

Placenta

Volumn 32, Issue 3, 2011, Pages 264-268

  Ornaghi, S ^a   Vergani, P ^a   Urban, G ^a   Giardini, V ^a   Moltrasio, F ^a   Leone, B E ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Annexin A5; Fetal growth restriction; Immunohistochemistry; Placenta; Preeclampsia

Indexed keywords

CORTICOSTEROID; LIPOCORTIN 5;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL AGE; NULLIPARA; PLACENTA; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; TISSUE MICROARRAY;

ANNEXIN A5; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; TISSUE ARRAY ANALYSIS;

EID: 79951960641     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2010.12.015     Document Type: Article

References (31)

1. Crumpton MJ, Dedman JR. Protein terminology tangle. Nature 1990;3465:212. (Pubitemid 20163049)
2. Moss SE, Morgan RO. The annexins. Genome Biol 2004;5:219.
3. Voges D, Berendes R, Burger A, Demange P, Baumeister W, Huber R. Three-dimensional structure of membrane-bound Annexin V. A correlative electron microscopy-X-ray crystallography study. J Mol Biol 1994;238:199-213.
4. Rand JH, Wu XX, Quinn AS, Chen PP, McCrae KR, Bovill EG, et al. Human monoclonal antiphospholipid antibodies disrupt the Annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 2003;163:1193-200. (Pubitemid 37040155)
5. Krikun G, Lockwood CJ, Wu XX, Zhou XD, Guller S, Calandri C, et al. The expression of the anticoagulant protein, Annexin V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 1994;15:601-12. (Pubitemid 24295067)
6. Wang X, Campos B, Kaetzel MA, Dedman JR. Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol 1999;180:1008-16. (Pubitemid 29200569)
7. Shu F, Sugimura M, Kanayama N, Kobayashi H, Kobayashi T, Terao T. Immunohistochemical study of Annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest 2000;49:17-23. (Pubitemid 30032416)
8. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15. (Pubitemid 28285299)
9. Matsuda J, Gotoh M, Saitoh N, Gohchi K. Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia. Thromb Res 1994;75:105-6. (Pubitemid 24223409)
10. Konijnenberg A, Stokkers EW, Van der Post JA, Schaap MC, Boer K, Bleker OP, et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 1997;176:461-9. (Pubitemid 27107940)
11. Crocker IP, Cooper S, OngSC, Baeker PN. Differences in apoptotic susceptibility of cytotrophoblast in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003;162:637-43. (Pubitemid 36267870)
12. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost 2003;89:486-92. (Pubitemid 36329239)
13. Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J, et al. Reduction of Annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol 1994;171:1566-72.
14. Wu XX, Arslan AA, Wein R, Reutelingsperger CP, Lockwood CJ, Kuczynski E, et al. Analysis of circulating Annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls. Am J Obstet Gynecol 2006;195:971-8. (Pubitemid 44415641)
15. Van Eerden P, Wu XX, Chazotte C, Rand JH. Annexin A5 levels in midtrimester amniotic fluid: association with intrauterine growth restriction. Am J Obstet Gynecol 2006;194:1371-6.
16. Arnold J, Holmes Z, Pickering W, Farmer C, Regan L, Cohen H, et al. Anti-beta2-glycoprotein 1 and anti-annexin V antibodies in women with recurrent miscarriage. Br J Haematol 2001;113:911-4. (Pubitemid 32634758)
17. Ogawa H, Zhao D, Dlott JS, Cameron GS, Yamazaki M, Hata T, et al. Elevated anti-annexin V antibodies levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am J Clin Pathol 2000;114:619-28. (Pubitemid 33044402)
18. Bizzaro N, Antico A, Musso M, Platzgummer S, Camogliano L, Tozzoli R, et al. A prospective study of 1038 pregnancies on the predictive value of anti-annexin V antibodies for fetal loss. Ann N Y Acad Sci 2005;1050:348-56. (Pubitemid 41129453)
19. Dundar O, Yoruk P, Tutuncu L, Muhcu M, Ipcioglu O, Ergur AR, et al. Second trimester amniotic fluid A5 levels and subsequent development of intrauterine growth restriction. Prenat Diagn 2008;28:887-91.
20. ACOG Practice Bulletin, ACOG Committee on Practice Bulletins-Obstetrics. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159-67.
21. Vergani P, Roncaglia N, Locatelli A, Andreotti C, Crippa I, Pezzullo JC, et al. Antenatal predictors of neonatal outcome in fetal growth restriction with absent end-diastolic flow in the umbilical artery. Am J Obstet Gynecol 2005;193:1213-8. (Pubitemid 41285522)
22. Redline RW, Faye-Petersen O, Heller D, Qureshi F, The Society for Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee, et al. Amniotic Infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003;6:435-48.
23. Redline RW, Boyd T, Campbell V, Hyde S, The Society for Pediatric Pathology, Perinatal Section, Maternal Vascular Underperfusion Nosology Committee, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:237-49.
24. Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 1986;55:244-8. (Pubitemid 16017550)
25. Richani K, Romero R, Yeon MK, Cushenberry E, Eleazar S, Yu MH, et al. Tissue microarray: an effective high-throughput method to study the placenta for clinical and research purposes. J Matern Fetal Neonatal Med 2006;19:509-15. (Pubitemid 44373624)
26. Torhorst J, Bucher C, Kononen J, Haas P. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56. (Pubitemid 33104278)
27. Hsu FD, Nielsen TO, Alkushi A. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 2002;15:1374-80. (Pubitemid 35463007)
28. Rand JH, Arslan AA, Wu XX, Wein R, Mulholland J, Shah M, et al. Reduction of circulating Annexin A5 levels and resistance to Annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol 2006;195:971-8. (Pubitemid 44415641)
29. Masuda J, Takajama E, Satoh A, Ida M, Shinohara T, Kojima-Aikawa K, et al. Levels of Annexin IV and V in the plasma of pregnant and postpartum women. Thromb Haemost 2004;91:1129-36. (Pubitemid 38821269)
30. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res 2008;75:1-8. (Pubitemid 350266733)
31. Sifakis S, Soufla G, Koukoura O, Soulitzis N, Koutroulakis D, Maiz N, et al. Decreased Annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction. Thromb Res 2010;125:326-31.